PharmaOpinionDeepMind’s AlphaGenome 2 Could Help Pharma Find Drug Targets Hidden in DNA
Genomics Limited plans to add DeepMind’s AlphaGenome 2 to Mystra, giving drugmakers a way to predict which genes a DNA variant affects and in which cells before deciding what to test.
